25-hydroxycholesterol has been researched along with Colorectal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dan, R; Hiraoka, Y; Hitsuda, A; Murakami, C; Tanaka, AR; Urakawa, A; Yamamoto, H | 1 |
Baquero, P; Calleros, L; Chiloeches, A; Sánchez-Hernández, I; Toro, MJ | 1 |
2 other study(ies) available for 25-hydroxycholesterol and Colorectal Neoplasms
Article | Year |
---|---|
25-hydroxycholesterol-induced cell death via activation of ROCK/LIMK/cofilin axis in colorectal cancer cell spheroids.
Topics: Actin Depolymerizing Factors; Antineoplastic Agents; Cell Death; Colorectal Neoplasms; HT29 Cells; Humans; Hydroxycholesterols; Lim Kinases; Protein Kinase Inhibitors; rho-Associated Kinases; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured | 2022 |
Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Topics: 3T3 Cells; Amino Acid Substitution; Animals; Apoptosis; Cattle; Cell Line, Tumor; Cholesterol; Colorectal Neoplasms; Enzyme Activation; Flow Cytometry; Genes, ras; HT29 Cells; Humans; Hydroxycholesterols; Lipoproteins; MAP Kinase Kinase 4; Mice; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Transfection | 2009 |